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Background: Primary antireflux surgery provides excellent symptom relief
in most patients. Unfortunately, the results of redo surgery are less
predictable. In these patients, esophageal injury from long-standing reflux
of gastric contents and operative trauma from previous failed antireflux
procedures results in progressive deterioration in esophageal propulsion, poor
clearance of reflux episodes, mucosal damage, and, in some cases, stricture
formation. For the past 16 years, we have selectively used esophageal resection
and replacement instead of another reoperation in these challenging patients.
Methods: Seventeen patients with end-stage esophageal body dysfunction and
one or more previously unsuccessful antireflux procedures underwent esoph-
agectomy and reconstruction by colon interposition in 15 patients and jejunum
interposition in 2 patients. The indications for esophagectomy rather than a
redo antireflux procedure were a global loss of effective esophageal motility in
13 and a nondilatable stricture in four. Their outcome was compared with that
of 32 patients with adequate motility and 18 with a similar global loss of
motility who had a redo antireflux procedure. Perioperative complications
after esophagectomy were recorded, and long-term outcome was assessed by
means of a standardized questionnaire at a median of 7 years after the
operation. Results: Patients with profound esophageal body dysfunction who
underwent esophageal resection had outcomes similar to those with normal
motility who underwent a redo antireflux procedure. Those with profound
esophageal motility dysfunction who underwent a redo antireflux procedure
had a worse outcome than those who underwent resection. Esophageal
resection and replacement was performed without mortality or graft failure.
All patients who underwent resection stated that their preoperative symptoms
were relieved completely (n 5 6) or improved (n 5 10). Thirteen patients (81%)
were able to eat three meals a day, and 12 patients (75%) enjoyed an
unrestricted diet. Two thirds of the patients were at or above their ideal body
weight, and 88% were fully satisfied with the outcome of the procedure.
Conclusion: Patients with end-stage esophageal body dysfunction who have had
a previous unsuccessful antireflux procedure can be treated by esophageal
resection with a high expectation of success. (J Thorac Cardiovasc Surg 1998;
115:296-302)
Antireflux surgery is a highly effective and durabletherapy in more than 90% of patients with
primary gastroesophageal reflux disease (GERD).1-3
The advent of laparoscopic fundoplication in 19914-6
has made surgical therapy of GERD more accept-
able. Unfortunately, some antireflux procedures fail,
and the successful outcome of a redo operation is
less predictable.7-9 In these patients, loss of esoph-
ageal function can result from long-standing reflux
of gastric contents or from operative trauma after
the previous unsuccessful antireflux procedure. This
results in poor clearance of reflux episodes, mucosal
damage, and occasional stricture formation. In this
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situation, a subsequent antireflux procedure may be
associated with a high failure rate, and esophageal
resection may be the better option.
We reviewed our experience with esophageal
resection and reconstruction in patients who had
profound esophageal body dysfunction and a history
of one or more previous unsuccessful antireflux
procedures to assess their long-term outcome and to
clarify the indications to proceed with resection as
opposed to attempting another repair.
Patients and methods
Between March 1980 and May 1996, 92 patients under-
went esophageal resection for benign disease. Of these, 17
had previously undergone one or more failed antireflux
procedures and their existing esophageal function had
deteriorated to the point where another repair was
thought unwise. Patients who underwent esophageal re-
section for named esophageal motility disorders were
excluded from this study. The medical records of these
patients were reviewed with respect to age, sex, symptoms,
previous operations, operative morbidity and mortality,
and length of hospital stay. Their outcome was compared
with a group of 50 consecutive patients who underwent
redo antireflux surgery after one or more previous antire-
flux procedures.
Preoperative esophageal body function was assessed by
stationary manometry in all patients who had a redo
antireflux procedure and in 14 of 17 patients who under-
went resection. In the remaining three patients the pres-
ence of a tight nondilatable stricture prevented the pas-
sage of the motility catheter. Esophageal manometry was
performed using a water-perfused catheter system with
radially oriented side ports placed 5 cm apart.10 The most
proximal side port was placed 1 cm below the lower
border of the upper esophageal sphincter, with the re-
maining ports trailing at 5 cm intervals. A series of 10 wet
swallows was performed, using 5 ml of water, and the
tracings obtained were analyzed on a commercially avail-
able software system (Polygram, Synectics Medical, Inc.,
Irving, Tex.). The results were compared with the values
obtained in a series of 50 asymptomatic volunteers.11
Swallows were considered to be simultaneous when the
velocity between two contraction peaks was 20 cm/sec or
faster. Propulsive failure was defined by a reduction in the
contraction amplitudes in the distal esophagus (below the
5th percentile of normal) or the presence of 40% or more
simultaneous waveforms in the distal two thirds of the
esophagus.
All patients underwent upper gastrointestinal endo-
scopy. Esophageal strictures were identified by the inabil-
ity to pass a 36F endoscope. Video esophagrams were
obtained in the supine and upright positions using liquid
barium, barium-impregnated hamburger, and radiopaque
pills in all but two patients. The presence of increased
esophageal acid exposure was documented by 24-hour pH
monitoring.12
A detailed symptomatic follow-up questionnaire was
completed, focusing on the side effects of the operation,
ability to aliment, and patient satisfaction with the proce-
dure (see Appendix). Asymptomatic patients were consid-
ered to have an excellent outcome. Patients with minor
symptoms requiring no therapy were considered to have a
good result. If there was an improvement in symptoms,
but intermittent therapy was required, the outcome was
considered fair. If their symptoms did not improve or
worsened, the outcome was considered poor.
For the purposes of comparison of outcome in the
respective treatment groups, the proportions having good/
excellent outcome were determined, and 95% confidence
limits for these proportions were calculated.
Clinical characteristics of patients who had esophageal
resection and reconstruction. The study population con-
sisted of 17 patients, 9 men and 8 women, with a median
age of 54 years (range 27 to 66 years). Eight patients had
undergone a single prior antireflux operation, whereas
five had undergone two and four had three or more
previous antireflux procedures. The types of prior proce-
dures are shown in Table I. In addition, six patients had
previous foregut surgery, including vagotomy and pyloro-
plasty, and one Billroth II resection.
Dysphagia was the predominant symptom, occurring in
10 patients despite a median of eight (range 1 to 25)
attempts at dilatation. Heartburn was the primary symp-
tom in four patients and regurgitation in three. All but
one of the patients with heartburn and regurgitation also
experienced dysphagia. Symptoms were present for a
median of nine years (range 1 to 30 years) before esoph-
agectomy.
All 17 patients showed evidence of organ failure as
manifested by a global loss of esophageal propulsion or
the presence of a nondilatable stricture. Eleven of the 14
patients in whom motility studies could be performed had
contraction amplitudes less than the 5th percentile of
normal, greater than 40% simultaneous waveforms, or
both. The remaining three patients had moderate degrees
of esophageal body dysfunction and had undergone three
or more antireflux procedures.
Esophagectomy was accomplished without thoracotomy
in nine patients, whereas the presence of dense adhesions
related to the previous antireflux operations required the
performance of a thoracotomy in eight. Fifteen patients
had reconstruction by colonic interposition.13 In two
patients with unsuitable colon arterial anatomy.14 a jeju-
nal reconstruction was done. In 10 patients the esophageal
replacement was anastomosed to the high posterior gas-
Table I. Antireflux operations before esophageal
replacement: types and numbers of procedures
performed
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tric wall. After experiencing difficulty with gastric empty-
ing after this type of reconstruction (severe enough to
require reoperation in two), a proximal two-thirds gastrec-
tomy was added in the subsequent five patients. Two
additional patients had a total gastrectomy performed
because of vagal denervation–mediated gastroparesis. The
length of hospitalization ranged from 12 to 24 days
(median 15 days). Follow-up evaluations were available in
16 of the 17 patients at a median of 7 years.
Clinical characteristics of patients who had a redo
antireflux procedure. A comparison group of 50 consec-
utive patients undergoing antireflux surgery in the setting
of one or more prior antireflux repairs was identified. This
group consisted of 28 male and 22 female patients, with a
median age of 54 years (range 22 to 77 years). Thirty-six
patients had undergone a single prior antireflux opera-
tion, whereas 11 had undergone two, and 3 had three or
more previous antireflux procedures.
Dysphagia was again the predominant symptom, occur-
ring in 24 patients. Heartburn was the primary symptom in
21, and five had regurgitation. Seven patients with heart-
burn and regurgitation also experienced dysphagia. The
redo antireflux procedures performed included a transab-
dominal Nissen fundoplication in five patients, a transtho-
racic Nissen in 21, a Belsey fundoplication in 14, and a
Collis-Belsey procedure in 10.
Of these 50 patients, 18 had evidence of esophageal
body failure manifested by contraction amplitudes less
than the 5th percentile of normal, more than 40% simul-
taneous contractions in the distal esophagus, or both.
Follow-up information was available in 49 of 50 who
underwent a redo antireflux procedure at a median of 2
years.
Results
The outcome after redo antireflux procedures
depended on esophageal body function in that pa-
tients with normal motility had a better outcome
than did patients with impaired esophageal motility
(Table II).
Patients with profound esophageal body dysfunc-
tion who underwent esophageal resection had out-
comes similar to patients with normal motility who
had a redo antireflux procedure.
Patients with profound esophageal body dysfunc-
tion who underwent a redo antireflux procedure had
an outcome that was worse than those who under-
went esophageal resection (Table II).
Perioperative complications occurred in four pa-
tients (24%) after esophagectomy, all of whom were
treated nonoperatively. Esophageal resection and
replacement was accomplished without mortality or
graft failure. During the follow-up period, five pa-
tients had late complications requiring surgical in-
tervention in two (Table III).
Thirteen patients (81%) in the esophagectomy
group were able to eat three meals a day, with a
capacity of 75% to 100% of normal. Twelve patients
were able to tolerate a completely unrestricted diet
without dysphagia. The change in body weight over
the follow-up period is shown in Fig. 1.
Discussion
The introduction of laparoscopic antireflux sur-
gery4, 5 has increased the frequency of surgical ther-
apy in the management of GERD. Although highly
effective in the primary setting,15 unfortunately
symptomatic failure occurs in some patients, and
repeat antireflux surgery is required. Clinical expe-
rience has shown that in certain situations a redo
fundoplication will be successful, but that in others
the esophagus may not be salvageable and replace-
ment may be required. However, objective criteria
to guide the surgeon in this difficult decision to
replace the esophagus are lacking.
Esophageal body motility is an important param-
eter in determining the outcome of a primary anti-
reflux procedure.16 This study shows that this ap-
plies to redo antireflux surgery as well. We have
shown that patients with normal esophageal motility
do well after redo antireflux surgery, whereas those
who undergo redo antireflux procedures with poor
esophageal propulsion are less likely to experience
Table II. Symptomatic outcome of patients with
normal and abnormal esophageal motility, who
underwent a redo antirefulx repair, compared with
patients who underwent esophageal replacement after






Normal motility (n 5 31) 28 (90%) 74.25-97.96
Abnormal motility (n 5 18) 10 (56%) 30.75-78.47
Overall (n 5 49) 38 (78%) 63.38-88.23
Esophagectomy (n 5 16) 14 (88%) 61.65-98.45
Table III. Early and late complications in patients
following esophagectomy after failed antireflux
surgery







Pneumonia 2 mo postoper-
atively
Pneumonia *Delayed gastric emptying
Neck wound infection Jejunostomy tube infection
Abdominal incision hernia
*Required surgical treatment.
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relief of their symptoms. In contrast, patients with
similar severe defects in esophageal motility who
undergo resection and replacement experience pre-
dictable relief.
Consequently, we propose that the specific indi-
cations for esophageal replacement in patients with
end-stage GERD and previously failed antireflux
procedures are the presence of dysphagia and
esophageal organ failure defined by manometric
criteria or the presence of an undilatable esophageal
stricture.
The manometric criteria we now use to identify
the presence of propulsive failure include the pres-
ence of more than 40% simultaneous waveforms,
contraction amplitudes less than the 5th percentile
of normal (,25 mm Hg), or both.
The question whether the stomach,17, 18 jeju-
num,19 or colon20-22 is the best organ to replace the
esophagus is not yet answered. It is generally ac-
cepted that the stomach is the preferred substitute
in patients with a limited life expectancy such as
those with esophageal carcinoma. However, in pa-
tients with a longer life expectancy, complications
after a gastric pull-up procedure, such as aspiration,
recurrent esophagitis, and development of Barrett’s
esophagus become evident.23 Furthermore, the pre-
vious attempts at antireflux surgery may preclude
the use of the stomach for reconstruction. Conse-
quently, in patients with benign disease requiring
esophageal replacement and in whom the esopha-
geal substitute must last for a decade or more, we
prefer to use the colon. In patients with benign
disease, reestablishment of gastrointestinal continu-
ity by a properly performed colon interposition has
been shown by this study and others to provide
excellent long-term function.13, 20, 24.25
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Discussion
Dr. Mark B. Orringer (Ann Arbor, Mich.). Dr. Hagen
has presented a very fine paper that attempts to answer an
important question: When is esophageal resection rather
than a redo repair the better option for the patient with a
failed antireflux operation?
The proposed indications for esophageal resection are
(1) the presence of dysphagia and a history of two
previous antireflux procedures; (2) the presence of an
undilatable stricture; and (3) esophageal organ failure
defined by manometric criteria, which in this case is 40%
or more simultaneous contractions in the distal two thirds
of the esophagus and contraction amplitude of less than
25%. I am in total agreement with the first two of these.
The 90% success rate of a properly performed initial
antireflux operation falls to 75% with the second and 50%
with the third. So after two failed antireflux operations,
whether the patient has dysphagia, resection provides a
more reliable and consistent long-term result. And an
undilatable stricture is clearly best treated by esophageal
resection. But the patient who has dysphagia after a prior
single antireflux operation is not as easily relegated to
esophageal resection, and I am concerned that nearly half
of your patients undergoing resection had only a single
previous antireflux procedure.
In a number of these patients a careful history reveals
that dysphagia, not reflux, was the predominant symptom
preoperatively, and the patient has had an inappropriate
antireflux operation performed for what is basically neu-
romotor dysfunction. This scenario is becoming quite
common in my referral practice where laparoscopic anti-
reflux surgery performed for increasingly lax indications is
providing a steady stream of therapeutic misadventures
and iatrogenic assaults on the gastroesophageal junction.
Esophageal dysmotility is often the result of functional
diseases of the alimentary tract. And the surgical treat-
ment of psychiatric disease is far from gratifying. These
patients are never happy whether their esophagus is in or
out, and nonoperative chronic dilatation therapy is often
the best option here.
All failures of antireflux surgery are not due to recur-
rent reflux or intrinsic dysmotility. For example, disrup-
tion of the crural repair may result in migration of the
fundoplication into the chest, loss of the normal vertical
esophageal axis, dysmotility, and a complaint of dysphagia
without a stricture, but with reduction of the hernia back
below the diaphragm and straightening of the esophagus,
dysphagia is relieved. Dr. Hagen, would you advise resec-
tion here simply because of abnormal esophageal motility
according to your criteria? And although you rely heavily
on manometric recordings, what has happened to the
good old barium swallow? You do not seem to place much
importance on this. If the patient with dysphagia after a
single antireflux operation has a normal caliber, normal-
thickness esophagus with some retained progressive peri-
stalsis, albeit less than 40% of contractions, is it not worth
trying one more time to salvage the esophagus? Did most
of your patients undergoing resection have dilated ana-
tomically end-stage esophagi, or have you defined “end-
stage” purely on the basis of manometric functional
criteria?
Finally, in discussing your functional results of esopha-
geal replacement, 88% were fully satisfied. Did none of
these patients require anastomotic dilation? Did none
experience regurgitation? Did none have significant
dumping symptoms?
In our experience, a thick-walled upper alimentary tract
organ–like stomach works better long term in the upper
alimentary tract than the thin-walled water absorption
chamber that colon is, and you do not see redundancy of
the stomach in the chest 10 to 15 years later. This is a
relative controversy that remains to be resolved.
Dr. Hagen. Thank you, Dr. Orringer, for your com-
ments and questions.
We do not believe that patients with underlying motility
disorders went unrecognized in this series as best as one
can possibly tell. We specifically excluded those patients
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who had evidence of a named esophageal motor disorder
on motility testing from this analysis. I recognize that in
some cases when there are profound disturbances in
esophageal motility, it may be impossible to tell the
difference between the two. However, as best as is possible
on the basis of the diagnostic tests available, we try to
exclude those patients from consideration here.
Your comments about patients who just do not seem to
be satisfied no matter what happens I think brings up a
very important point. Most of the patients who have failed
antireflux procedures in whom we recommend esophagec-
tomy are offered this procedure after careful discussion.
We really take a great deal of time to bring them along
before the procedure is actually performed, in many cases
months or years before they might make the decision to
proceed with resection. I would agree completely that it is
not something that should be entered into lightly.
Clearly, if you could identify on a preoperative upper
gastrointestinal study or on the motility study a specific
technical problem that you might be able to correct, it may
be worth considering another antireflux operation. How-
ever, in the patients studied here that simply was not the
case. The study patients had profound esophageal failure,
many of them with significant esophagitis and a few
nondilatable strictures. Under these circumstances, going
ahead with another attempt at repair would be unwise.
I do not know that the question of whether the stomach,
colon, or jejunum is the ideal replacement organ can be
resolved on the basis of this particular study. This obvi-
ously remains a subject of debate. It has been our
experience that the colon works extremely well in the long
term and has remained our preferred organ of esophageal
substitution in patients in whom the life expectancy is
long. The other issue to consider with remedial operations
is that after two, three, or four prior antireflux operations,
the stomach is not always in the best shape to be used as
a reconstructive organ.
Dr. Douglas J. Mathisen (Boston, Mass.). Could you tell
me what the indications were for gastrectomy? I notice
that there were seven patients that you indicated had
either partial or total gastrectomy. I am not clear on how
many had which. And finally, it was implied that if all
things are equal, you prefer a long colon interposition as
opposed to a short colon or jejunal interposition. Is that
correct, or did I misinterpret your statement about that?
Dr. Hagen. No, that is correct. For esophageal recon-
struction in benign diseases, we prefer long-segment colon
interposition with the anastomosis performed in the neck.
Again, whenever possible, we try and accomplish the
esophagectomy transhiatally.
In most of the patients who underwent a partial gastric
resection, it was resection of the upper stomach. We have
found the functional results after colon interposition seem
to be better when the colon is anastomosed to the antrum.
When the colon is anastomosed to a denervated fundus,
there are often problems with gastric retention. In fact,
one of the patients who was reoperated on over the
long-term follow-up had just that problem.
Dr. F. Griffith Pearson (Toronto, Ontario, Canada). I
just wanted to lend support to the opinion expressed by
Dr. Orringer: I think it is potentially excessive treatment
to recommend esophagectomy and long colon interposi-
tion in a patient who fails after one repair and in whom
you have the described disorders. Without having re-
viewed our own experience, I do not believe one should
anticipate a 50% failure rate for a second antireflux repair
in the face of the motility disorder described here. We use
motility in all of our patients. The finding of this type of
hypomotility disorder in the distal two thirds of the
thoracic esophagus is common in reflux disease, whether
they are first-time or second-time operations. Again,
although I have not reviewed the material, what you are
saying does not jibe with what I think we see. More
important, I do not believe that we should anticipate, even
in 1997, that most surgeons will do a series of consecutive
colon replacements with no mortality and with so little
morbidity. One inevitably divides both vagus nerves, cre-
ates a gastric motility problem that is going to give
symptoms in some patients, and one needs a very long-
term follow-up, as Dr. Orringer implies, to judge results
after colon replacement. I have lived long enough to have
some long-term follow-up and have now replaced a few of
the colon interpositions I did 20 and 30 years ago, these
patients had an initial satisfactory result for many years.
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